Huawei Smartwatch Classified as Medical Device, Eligible for Insurance Reimbursement

The Huawei WATCH D2 boasts a notable medical function - the ability to measure and record blood pressure, categorizing it as a "medical device" under policy regulations that allow for reimbursement through personal medical insurance accounts. Beyond its health-monitoring capabilities, the smartwatch also features Bluetooth calling and WeChat payment, showcasing its versatility as both a medical tool and a daily convenience device.

An investigation by Red Star Capital Bureau found that the Huawei WATCH D2 is a second-class medical device, approved by the Guangdong Provincial Drug Administration on August 5, 2024. The product's main function is to measure and record the user's blood pressure, and it has been certified by multiple countries. However, the product also has many additional features that are not primarily used for medical purposes, which has raised questions about its eligibility for medical insurance reimbursement.

Social media is abuzz with discussions about the eligibility of Huawei smartwatches for medical insurance reimbursement. Many users have shared their experiences of purchasing the devices using their medical insurance personal accounts, viewing it as a win-win situation where the product receives authoritative validation and sales are boosted, while consumers reap the benefits. However, not everyone is convinced, with some questioning the rationale behind such purchases, arguing that medical insurance should not be used to cover the costs of these products.

The National Medical Insurance Bureau has also weighed in on the matter, stating that products with a registered medical device certificate, such as the Huawei WATCH D2, are eligible for medical insurance reimbursement. However, the bureau emphasized that specific reimbursement policies may vary depending on local regulations. The Ningbo Medical Insurance Bureau has temporarily suspended the purchase of the Huawei WATCH D2 using medical insurance, citing the product's many additional features that are not primarily used for medical purposes. The final decision on whether to allow the product to be purchased using medical insurance will depend on local regulations and policies.

In conclusion, the classification of the Huawei WATCH D2 as a second-class medical device has sparked a debate about whether it can be purchased using a personal medical insurance account. While some pharmacies are selling the product and allowing customers to use their medical insurance accounts, others have suspended sales due to the product's many additional features that are not primarily used for medical purposes. As the situation continues to unfold, consumers are advised to consult with local medical insurance authorities and pharmacies to determine the specific requirements and procedures for purchasing the Huawei WATCH D2 using medical insurance.